As one of the top priorities of the national Danish National life Science strategy, the initiaive, Trial Nation, which offers a single, national entry point for global companies, patient organisations and clinical researchers wishing to conduct clinical trials in Denmark,
Below you will find the latest news from MVA. You can also sign up to our newsletter MVA Update.
MVA Update is an electronic newsletter providing you with news about MVA and an overview of our events and other relevant events in Medicon Valley. You can also check out our calendar for more information about life science events in the region.
If you have any questions regarding our news section or media inquiries then please contact David Munis Zepernick, Head of Press on +45 2498 1668.
2cureX AB invites shareholders and the public to attend an investor meeting in Stockholm. The company will present the ongoing operations, the way forward for 2cureX and the offer for the company’s ongoing rights issue. The investor meeting is held
At yesterday´s ordinary general meeting, MVA CEO Petter Hartman, highlighted some of the key challenges and succes stories from 2018, including the fact that the MVA-family had the pleasure of welcoming 48 new members and saw a 20% increase in
The Danish daily, Politiken, recently published an opinion piece by Søren Ziebe, professor, head of the fertility clinic at Rigshospitalet and part of the ReproUnion collaboration, and Ole Sohn, chairman of the board at Cryos ” titled “The children we
“Danish life science is heading for a new golden age”! This is one of the statements put forward in today´s article in Danish daily, Berlingske, highlighting MVA-member, Bioinnovation Institute, and their role as incubator for promising life science companies. A
The annual “Greater Copenhagen Life Science Yearbook” is now awailable online. Apart from the editorial “JOIN FORCES – We are strongest together” by MVA chairman of the Board and Chief Business Officer of IO Biotech, Søren Bregenholt (a must read,
MVA-members and life science decision-makers should all read the recently published and translated article “Venture funds see golden opportunities in Oresunds’s life science hub“(Medwatch subscription needed). A number of prominent experts are interviewed about the potential for venture capital in
The chairman of Medicon Valley Alliance, Søren Bregenholt´s quarterly business column in Copenhagen Post “The Valley of Life: Britain is still key!” has just been published. Read the relatively optimistic analysis of the brexit situation and it´s likely consequences for
In an interview with LIFe-time.se, Medicon Valley Alliance CEO, Petter Hartman, is commenting on the new proposals for strengthening life science in Region Skåne. The region needs to be even better at attracting clinical trials, but what else is needed?